UK medical cannabis patients have been told that they’ll have access to a six-month stockpile of Bedrolite, following weeks of uncertainty in the wake of Bedrocan’s collapse.
PGP Farmer, the French biotech developing what it describes as the country’s first EU-GMP medical cannabis production site, has launched a proof-of-concept phenotyping programme in the Netherlands, testing 30 cannabis genotypes from its own genetic library to determine which varieties will be cultivated at its Dordogne facility.
The M&A scramble for Europe has continued at a fearsome pace over the last few weeks.
We have delved into some of the key data and insights set to be integrated into the new site, providing a taste of what readers can expect. For further exclusive analysis into the European cannabis market, pre-orders for data packages are available now.
From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.
Bedrocan, one of Europe’s largest and longest-running suppliers of pharmaceutical and medical cannabis, has announced plans to commercialise a new high-CBD strain of cannabis, Bedrolina.
The Netherlands has delayed the official start of its ‘controlled cannabis supply chain experiment’ amid ongoing teething problems in establishing domestic supply.
The Netherland’s long-awaited and repeatedly delayed ‘controlled cannabis supply chain experiment’ has now been running in its entirety for over a month.
Bedrocan, which for years has only supported external researchers financially, today announced the launching of its own Clinical Research Unit to conduct research into the effects of the cannabis products it produces on behalf of the Dutch government.
